🇺🇸 FDA
Patent

US 10849988

Hydrogel for engineered immune response to D-chirality peptides

granted A61KA61K2039/55516A61K2039/6031

Quick answer

US patent 10849988 (Hydrogel for engineered immune response to D-chirality peptides) held by The Regents of the University of California expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/55516, A61K2039/6031, A61K2039/6093, A61K2039/64